Antiperspirant compositions
    2.
    发明授权
    Antiperspirant compositions 有权
    止汗组合物

    公开(公告)号:US06652843B2

    公开(公告)日:2003-11-25

    申请号:US10346676

    申请日:2003-01-17

    IPC分类号: A61K732

    摘要: Clear solid suspension antiperspirant compositions comprise 0.5 to 50% by weight of a particulate antiperspirant active material of which less than 50% by weight of its particles are below 110pm diameter and a refractive index of from 1.49 to 1.57 at 22° C. is suspended in a water-immiscible carrier liquid of which at least 50% by weight is selected from liquid non-volatile silicone oils and liquid alkyl-aryl esters and not more than 25% by weight of the carrier liquid comprises a volatile silicone oil. The carrier liquid and the antiperspirant have refractive indexes which differ by no more than 0.02 at 22° C and the structurant which solidifies the carrier liquid comprises a fibre-forming non-polymeric structurant, and preferably an N-acyl aminoacid amide such as GPl and/or a cyclodipeptide such as a thymol derivative of (2S-cis)-(−)-5-benzyl-3,6-dioxo-2-piperazine acetic acid.

    摘要翻译: 透明固体悬浮剂止汗剂组合物包含0.5至50重量%的粒状止汗活性物质,其中小于50重量%的颗粒的直径小于110μm,折射率为1.49-1.57,在22℃下悬浮 选自液体非挥发性硅油和液体烷基 - 芳基酯和不超过25重量%载体液体的至少50重量%的水不混溶载体液体包含挥发性硅油。 载液和止汗剂的折射率在22℃下的折射率不同于0.02,固化载体液的结构剂包括形成纤维的非聚合结构剂,优选为N-酰基氨基酸酰胺如GP1和 /或环二肽如(2S-顺式) - ( - ) - 5-苄基-3,6-二氧代-2-哌嗪乙酸的百里酚衍生物。